India Today on MSN

India's next leap: Homegrown biotech push spurs hope for affordable next-gen drugs for cancers, other serious conditions

The move follows similar initiatives by players like Syngene, Laurus Labs, and Aragen. Industry analysts see Bharat Biotech’s ...